BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $60,651,000 | +19.0% | 932,944 | +33.8% | 0.45% | +2.3% |
| Q2 2020 | $50,960,000 | +71.0% | 697,038 | -20.4% | 0.44% | +37.5% |
| Q1 2020 | $29,800,000 | -9.0% | 875,710 | +45.6% | 0.32% | +12.3% |
| Q4 2019 | $32,739,000 | +684.7% | 601,370 | +501.4% | 0.28% | +650.0% |
| Q3 2019 | $4,172,000 | -36.5% | 100,000 | -33.3% | 0.04% | -34.5% |
| Q2 2019 | $6,569,000 | -7.1% | 150,000 | +9.2% | 0.06% | -12.1% |
| Q1 2019 | $7,068,000 | +27.4% | 137,331 | -8.4% | 0.07% | +11.9% |
| Q4 2018 | $5,547,000 | -29.7% | 150,000 | -24.8% | 0.06% | +25.5% |
| Q2 2018 | $7,888,000 | – | 199,600 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |